Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging

Study Design

Subject Type

Human

Trial Design

Open-Label

Trial Duration

84 days

Participants

10 (10 completed)

Age Range

54-67 years

Efficacy

Intervention(s)			Outcome		Method		Effect	Description
Isdinceutics Melaclear			Facial Pores		Clinical grading		⇩	Sign in to read for free
Sign in to read for free
Isdinceutics Melaclear			Hyperpigmentation		Clinical grading		⇩	Sign in to read for free
Sign in to read for free
Isdinceutics Melaclear			Melasma		Clinical grading		⇩	Sign in to read for free
Sign in to read for free
Isdinceutics Melaclear			Skin Brightness		Clinical grading		⇧	Sign in to read for free
Sign in to read for free
Isdinceutics Melaclear			Skin Redness		Clinical grading		–	Sign in to read for free
Sign in to read for free
Isdinceutics Melaclear			Skin Smoothness		Clinical grading		⇧	Sign in to read for free
Sign in to read for free

Side Effects

Intervention(s)			Outcome		Effect	Description
Isdinceutics Melaclear			Skin Discomfort		⇧	Sign in to read for free
Sign in to read for free

Study Summary

Sign in to read for free